Certified by Founder
Lodge
Pragma Bio
start up
United States
- South San Francisco, California
- 27/03/2023
- Unknown
- $10,000,000
Pragma Bio exists to find cures for undruggable immunological disorders. We use real-world data and synthetic biology to map out multi-omic signatures associated with clinical outcomes in order to produce microbial-derived small molecules with therapeutic potential.
- Industry Biotechnology
- Website https://www.pragmabio.com/
- LinkedIn https://www.linkedin.com/company/pragmabio/
EnerVenue | $300,000,000 | (Apr 3, 2026)
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
daydream | $15,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Alien | $7,100,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
Linx Security | $50,000,000 | (Apr 2, 2026)
Earlyasset | $2,000,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
Whirl AI | $8,900,000 | (Apr 2, 2026)